{"nctId":"NCT02106351","briefTitle":"Efficacy And Safety Of Dysport In The Treatment Of Upper Limb Spasticity In Children","startDateStruct":{"date":"2014-04","type":"ACTUAL"},"conditions":["Upper Limb Spasticity (Altered Skeletal Muscle Performance) in Children"],"count":212,"armGroups":[{"label":"Group A","type":"EXPERIMENTAL","interventionNames":["Biological: Botulinum toxin type A"]},{"label":"Group B","type":"EXPERIMENTAL","interventionNames":["Biological: Botulinum toxin type A"]},{"label":"Group C","type":"EXPERIMENTAL","interventionNames":["Biological: Botulinum toxin type A"]}],"interventions":[{"name":"Botulinum toxin type A","otherNames":["AbobotulinumtoxinA (Dysport®)"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Upper limb spasticity due to cerebral palsy\n* Body weight 10 kg or over\n* MAS score of 2 or more in affected elbow or wrist flexors\n\nExclusion Criteria:\n\n* Fixed myocontracture\n* Previous phenol or alcohol injection within 1 year\n* Severe athetoid or dystonic movements\n* Previous or planned surgery for spasticity in elbow or wrist flexors\n* Neuromuscular disorders\n* Previous Rhizotomy within 6 months\n* Intrathecal baclofen within 30 days","healthyVolunteers":false,"sex":"ALL","minimumAge":"2 Years","maximumAge":"17 Years","stdAges":["CHILD"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Mean Change From Baseline to TC 1, Week 6 in MAS Score in the TC 1 PTMG","description":"The MAS was used to assess muscle tone in the upper limb PTMG and consists of 6 grades: 0 (no increase in muscle tone), 1 (slight increase in muscle tone, manifested by a catch and release or by minimal resistance at the end of the ROM) when the affected part is moved in flexion or extension, 1+ (slight increase in muscle tone, manifested by a catch, followed by minimal resistance throughout the remainder (less than half) of the ROM), 2 (more marked increase in muscle tone), 3 (considerable increase in muscle tone) or 4 (affected part(s) rigid in flexion or extension). The original score '+1' was given a derived numeric score of '2' and the higher numeric scores were incremented by 1 so that the MAS score range was from 0 to 5 with higher scores indicating greater muscle tone. A negative change from baseline indicates a decrease in muscle tone.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.5","spread":"1.1"},{"groupId":"OG001","value":"-1.9","spread":"1.0"},{"groupId":"OG002","value":"-2.2","spread":"0.9"}]}]}]},{"type":"SECONDARY","title":"Mean Physician's Global Assessment (PGA) Score at TC 1, Week 6","description":"The PGA of treatment response was assessed by asking the investigator the following question: 'How would you rate the response to treatment in the subject's upper limb since the start of the study?'. Answers were on a 9-point rating scale (-4: markedly worse, -3: much worse, -2: worse, -1: slightly worse, 0: no change, +1: slightly improved, +2: improved, +3: much improved and +4: markedly improved). The mean scores for each treatment group at TC 1, Week 6 are presented.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.7","spread":"0.9"},{"groupId":"OG001","value":"2.0","spread":"0.9"},{"groupId":"OG002","value":"2.0","spread":"0.9"}]}]}]},{"type":"SECONDARY","title":"Mean Goal Attainment Scale (GAS) Total Score at TC 1, Week 6","description":"The GAS is a functional 5-point scale used to measure progress towards individual therapy goals. At start of each TC, 1 to 3 individual goals were defined for each subject by investigator and child's parents/guardians/caregivers prior to treatment. Outcome to reach each goal was rated on a 5-point scale ranging from -2 to +2 (-2: much less than expected outcome, -1: somewhat less than expected outcome, 0: expected outcome, +1: somewhat more than expected outcome, +2: much more than expected outcome). Higher score indicates a better outcome. A GAS T-score was calculated as: 50+(10∑\\_(i=1)\\^n wi xi)/√(0.7∑\\_(i=1)\\^n wi\\^2 +0.3(∑\\_(i=1)\\^n wi)\\^2) where, xi = rating of ith goal post-baseline; wi = weight of ith goal, calculated as importance \\* difficulty as defined at baseline; n = number of goals assessed at baseline and post-baseline. A GAS T-score of 50 indicates goals achieved as expected. Scores below 50 reflect under attainment of goals and scores above 50 reflect over attainment of goals.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"51.3","spread":"9.9"},{"groupId":"OG001","value":"52.6","spread":"10.1"},{"groupId":"OG002","value":"52.0","spread":"9.6"}]}]}]},{"type":"OTHER_PRE_SPECIFIED","title":"Mean Change From Baseline to TC 1 Week 16 in MAS Score in the TC 1 PTMG","description":"The MAS was used to assess muscle tone in the upper limb PTMG and consists of 6 grades: 0 (no increase in muscle tone), 1 (slight increase in muscle tone, manifested by a catch and release or by minimal resistance at the end of the ROM) when the affected part is moved in flexion or extension, 1+ (slight increase in muscle tone, manifested by a catch, followed by minimal resistance throughout the remainder (less than half) of the ROM), 2 (more marked increase in muscle tone), 3 (considerable increase in muscle tone) or 4 (affected part(s) rigid in flexion or extension). The original score '+1' was given a derived numeric score of '2' and the higher numeric scores were incremented by 1 so that the MAS score range was from 0 to 5 with higher scores indicating greater muscle tone. A negative change from baseline indicates a decrease in muscle tone.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.0","spread":"1.0"},{"groupId":"OG001","value":"-1.4","spread":"1.1"},{"groupId":"OG002","value":"-1.6","spread":"1.2"}]}]}]},{"type":"OTHER_PRE_SPECIFIED","title":"Mean Change From Baseline to TC 1 Weeks 6 and 16 in MAS Score in the Elbow Flexors of the Study Limb","description":"The MAS was used to assess muscle tone in the upper limb PTMG and consists of 6 grades: 0 (no increase in muscle tone), 1 (slight increase in muscle tone, manifested by a catch and release or by minimal resistance at the end of the ROM) when the affected part is moved in flexion or extension, 1+ (slight increase in muscle tone, manifested by a catch, followed by minimal resistance throughout the remainder (less than half) of the ROM), 2 (more marked increase in muscle tone), 3 (considerable increase in muscle tone) or 4 (affected part(s) rigid in flexion or extension). The original score '+1' was given a derived numeric score of '2' and the higher numeric scores were incremented by 1 so that the MAS score range was from 0 to 5 with higher scores indicating greater muscle tone. A negative change from baseline indicates a decrease in muscle tone. Data is presented for subjects injected in the elbow flexors.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.0","spread":"1.1"},{"groupId":"OG001","value":"-1.7","spread":"1.1"},{"groupId":"OG002","value":"-1.9","spread":"1.2"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.6","spread":"1.0"},{"groupId":"OG001","value":"-1.2","spread":"1.2"},{"groupId":"OG002","value":"-1.3","spread":"1.4"}]}]}]},{"type":"OTHER_PRE_SPECIFIED","title":"Mean Change From Baseline to TC 1 Weeks 6 and 16 in MAS Score in the Wrist Flexors of the Study Limb","description":"The MAS was used to assess muscle tone in the upper limb PTMG and consists of 6 grades: 0 (no increase in muscle tone), 1 (slight increase in muscle tone, manifested by a catch and release or by minimal resistance at the end of the ROM) when the affected part is moved in flexion or extension, 1+ (slight increase in muscle tone, manifested by a catch, followed by minimal resistance throughout the remainder (less than half) of the ROM), 2 (more marked increase in muscle tone), 3 (considerable increase in muscle tone) or 4 (affected part(s) rigid in flexion or extension). The original score '+1' was given a derived numeric score of '2' and the higher numeric scores were incremented by 1 so that the MAS score range was from 0 to 5 with higher scores indicating greater muscle tone. A negative change from baseline indicates a decrease in muscle tone. Data is presented for subjects injected in the wrist flexors.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.3","spread":"1.1"},{"groupId":"OG001","value":"-1.5","spread":"1.2"},{"groupId":"OG002","value":"-1.7","spread":"1.3"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.9","spread":"1.2"},{"groupId":"OG001","value":"-1.0","spread":"1.2"},{"groupId":"OG002","value":"-1.3","spread":"1.2"}]}]}]},{"type":"OTHER_PRE_SPECIFIED","title":"Mean Change From Baseline to TC 1 Weeks 6 and 16 in MAS Score in the Finger Flexors of the Study Limb","description":"The MAS was used to assess muscle tone in the upper limb PTMG and consists of 6 grades: 0 (no increase in muscle tone), 1 (slight increase in muscle tone, manifested by a catch and release or by minimal resistance at the end of the ROM) when the affected part is moved in flexion or extension, 1+ (slight increase in muscle tone, manifested by a catch, followed by minimal resistance throughout the remainder (less than half) of the ROM), 2 (more marked increase in muscle tone), 3 (considerable increase in muscle tone) or 4 (affected part(s) rigid in flexion or extension). The original score '+1' was given a derived numeric score of '2' and the higher numeric scores were incremented by 1 so that the MAS score range was from 0 to 5 with higher scores indicating greater muscle tone. A negative change from baseline indicates a decrease in muscle tone. Data is presented for subjects injected in the finger flexors.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.8","spread":"0.9"},{"groupId":"OG001","value":"-1.8","spread":"1.1"},{"groupId":"OG002","value":"-1.9","spread":"1.0"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.8","spread":"1.3"},{"groupId":"OG001","value":"-1.3","spread":"0.8"},{"groupId":"OG002","value":"-1.8","spread":"1.0"}]}]}]},{"type":"OTHER_PRE_SPECIFIED","title":"Mean PGA Score at TC 1 Week 16","description":"The PGA of treatment response was assessed by asking the investigator the following question: 'How would you rate the response to treatment in the subject's upper limb since the start of the study?'. Answers were on a 9-point rating scale (-4: markedly worse, -3: much worse, -2: worse, -1: slightly worse, 0: no change, +1: slightly improved, +2: improved, +3: much improved and +4: markedly improved). The mean scores for each treatment group at TC 1 Week 16 are presented.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.7","spread":"1.0"},{"groupId":"OG001","value":"1.6","spread":"1.1"},{"groupId":"OG002","value":"1.9","spread":"1.2"}]}]}]},{"type":"OTHER_PRE_SPECIFIED","title":"Mean GAS Total Score at TC 1, Week 16","description":"The GAS is a functional 5-point scale used to measure progress towards individual therapy goals. At start of each TC, 1 to 3 individual goals were defined for each subject by investigator and child's parents/guardians/caregivers prior to treatment. Outcome to reach each goal was rated on a 5-point scale ranging from -2 to +2 (-2: much less than expected outcome, -1: somewhat less than expected outcome, 0: expected outcome, +1: somewhat more than expected outcome, +2: much more than expected outcome). Higher score indicates a better outcome. A GAS T-score was calculated as: 50+(10∑\\_(i=1)\\^n wi xi)/√(0.7∑\\_(i=1)\\^n wi\\^2 +0.3(∑\\_(i=1)\\^n wi)\\^2) where, xi = rating of ith goal post-baseline; wi = weight of ith goal, calculated as importance \\* difficulty as defined at baseline; n = number of goals assessed at baseline and post-baseline. A GAS T-score of 50 indicates goals achieved as expected. Scores below 50 reflect under attainment of goals and scores above 50 reflect over attainment of goals.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"54.7","spread":"9.8"},{"groupId":"OG001","value":"54.2","spread":"9.7"},{"groupId":"OG002","value":"55.1","spread":"10.1"}]}]}]},{"type":"OTHER_PRE_SPECIFIED","title":"Mean Change From Baseline to TC 1, Week 16 in the Paediatric Quality of Life (PedsQL) Scores","description":"Parents/guardians completed questionnaires on their child's quality of life. The PedsQL parent inventory measured healthcare concepts for children/adolescents aged 2-18 years. The Generic Core Scales include physical, emotional, social and school aspects. The CP module was also completed. Scores were transformed on a scale from 0 to 100 with higher scores indicating a better quality of life. Mean changes from baseline to TC 1, Week 16 are presented for the General Core Scale and for the CP module. A positive change from baseline indicates an improvement in quality of life.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"3.4","spread":"9.7"},{"groupId":"OG001","value":"3.4","spread":"17.1"},{"groupId":"OG002","value":"2.0","spread":"12.0"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.8","spread":"16.8"},{"groupId":"OG001","value":"2.1","spread":"14.9"},{"groupId":"OG002","value":"2.8","spread":"16.2"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":4,"n":70},"commonTop":["Viral upper respiratory tract infection","Upper respiratory tract infection","Pharyngitis","Pyrexia","Muscular weakness"]}}}